Search

Your search keyword '"Craxi A."' showing total 1,617 results

Search Constraints

Start Over You searched for: Author "Craxi A." Remove constraint Author: "Craxi A."
1,617 results on '"Craxi A."'

Search Results

1. A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort

2. A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort

4. Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories

5. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

6. Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease

7. A global research priority agenda to advance public health responses to fatty liver disease

8. Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries

10. Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination

12. FRI-405 Heterogeneity in the diagnostic performances of HDV-RNA quantification assays used in clinical practice in Italy: results from a national quality control multicenter study

15. Health Care at the Time of COVID-19

16. Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

17. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

18. Liver transplantation for severe alcoholic hepatitis: A multicenter Italian study

19. A randomized, placebo‐controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis

20. Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort

21. A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and Delta cohort

24. Metabolic comorbidities and male sex influence steatosis in chronic hepatitis C after viral eradication by direct-acting antiviral therapy (DAAs): Evaluation by the controlled attenuation parameter (CAP)

26. Effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients: Results of the Italian cohort of a post-marketing observational study

27. Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver Disease

30. Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents

35. Profiling the risk of hepatocellular carcinoma after long-term HCV eradication in patients with liver cirrhosis in the PITER cohort

36. A global research priority agenda to advance public health responses to fatty liver disease

37. Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis

38. Update of the statements on biology and clinical impact of occult hepatitis B virus infection

39. Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients

41. The adjusted prevalence of hepatitis delta virus (HDV) in 25 countries and territories

43. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030

45. Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosis

46. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

47. Programmed cell death 1 genetic variant and liver damage in non-alcoholic fatty liver disease

48. Presence and severity of esophageal varices drives portal hypertension-related complications in compensated advanced non-alcoholic fatty liver disease

Catalog

Books, media, physical & digital resources